A detailed history of Public Sector Pension Investment Board transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Public Sector Pension Investment Board holds 88,350 shares of BMY stock, worth $5.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
88,350
Previous 77,950 13.34%
Holding current value
$5.02 Million
Previous $3.24 Million 41.24%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $412,463 - $538,200
10,400 Added 13.34%
88,350 $4.57 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $1.3 Million - $1.72 Million
32,407 Added 71.16%
77,950 $3.24 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $283,082 - $320,960
5,900 Added 14.88%
45,543 $2.47 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $8.93 Million - $10.7 Million
-184,136 Reduced 82.28%
39,643 $2.03 Million
Q3 2023

Nov 22, 2023

BUY
$57.89 - $64.73 $1.31 Million - $1.46 Million
22,610 Added 11.24%
223,779 $13 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $2.09 Million - $2.32 Million
-32,753 Reduced 14.0%
201,169 $12.9 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $40.8 Million - $46.3 Million
-621,239 Reduced 72.65%
233,922 $16.2 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $3.28 Million - $3.89 Million
-47,963 Reduced 5.31%
855,161 $61.5 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $21,437 - $12.7 Million
-164,907 Reduced 15.44%
903,124 $64.2 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $55.3 Million - $61 Million
762,185 Added 249.21%
1,068,031 $82.2 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $83.9 Million - $101 Million
-1,364,530 Reduced 81.69%
305,846 $22.3 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $319,473 - $372,431
-5,957 Reduced 0.36%
1,670,376 $104 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $78.4 Million - $91.8 Million
1,324,817 Added 376.89%
1,676,333 $99.2 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $8.06 Million - $8.77 Million
130,154 Added 58.8%
351,516 $23.5 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $2.05 Million - $2.31 Million
34,586 Added 18.52%
221,362 $14 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $5.04 Million - $5.71 Million
-87,266 Reduced 31.84%
186,776 $11.6 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $3.2 Million - $3.55 Million
55,806 Added 25.57%
274,042 $16.5 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $882,602 - $1.03 Million
-16,100 Reduced 6.87%
218,236 $12.8 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $24.2 Million - $35.2 Million
-522,420 Reduced 69.03%
234,336 $13.1 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $21.6 Million - $28.2 Million
439,113 Added 138.24%
756,756 $48.6 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $4.45 Million - $5.28 Million
104,037 Added 48.71%
317,643 $16.1 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $8.93 Million - $9.88 Million
-200,178 Reduced 48.38%
213,606 $9.69 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $12.3 Million - $14.7 Million
-272,408 Reduced 39.7%
413,784 $19.7 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $29.7 Million - $38.5 Million
609,586 Added 795.74%
686,192 $35.7 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $5.23 Million - $5.9 Million
-94,800 Reduced 55.31%
76,606 $4.76 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $4.04 Million - $5.04 Million
80,000 Added 87.52%
171,406 $9.49 Million
Q1 2018

May 10, 2018

SELL
$59.92 - $68.98 $30.9 Million - $35.6 Million
-515,807 Reduced 84.95%
91,406 $5.78 Million
Q4 2017

Feb 02, 2018

BUY
$59.94 - $65.35 $605,394 - $660,035
10,100 Added 1.69%
607,213 $37.2 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $33 Million - $38.1 Million
597,113
597,113 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.